James P. Brady
Human Resources Officer en SPERO THERAPEUTICS, INC. .
Cargos activos de James P. Brady
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
SPERO THERAPEUTICS, INC. | Human Resources Officer | - | - |
Historial de carrera de James P. Brady
Antiguos cargos conocidos de James P. Brady.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
UNIQURE N.V. | Human Resources Officer | 01/08/2020 | - |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Human Resources Officer | 01/04/2015 | - |
Formación de James P. Brady.
Harvard University | Graduate Degree |
Marietta College | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 5 |
Países Bajos | 2 |
Operativa
Human Resources Officer | 3 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sectorial
Health Technology | 4 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
UNIQURE N.V. | Health Technology |
SPERO THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Health Technology |
- Bolsa de valores
- Insiders
- James P. Brady
- Experiencia